{"Clinical Trial ID": "NCT01351376", "Intervention": ["INTERVENTION 1:", "- Placebo", "CDT + Inactive LLL", "Low-level laser therapy: Placebo LLL combined with CDT", "INTERVENTION 2:", "- LLL combined with CDT", "CDT + LLL active", "Low-level Laser: Active LLL combined with CDT"], "Eligibility": ["Incorporation criteria:", "- Unilateral breast cancer with ipsilateral lumpectomy or mastectomy and lymph node dissection (sensinel biopsy or axillary dissection)", "Phase II or III unilateral secondary lymphedema of the upper extremity (as defined by the International Society of Lymphology)", "Circumferential difference of 2 cm and/or volume of 200 mL compared to the upper end not involved in any 4 cm segment", "In a position to commit to a long-term follow-up schedule", "- Exclusion criteria:", "Active cancer/metastatic cancer", "Currently, receive or have plans for adjuvant radiation or chemotherapy", "Pregnant women", "Other lymphedema of the extremities (primary or secondary)", "- Heart stimulator", "\u2022 Artificial joints in the upper quadrants", "Renal impairment", "Insufficiency of arterial function", "Congestive heart failure", "Chronic inflammatory disorders", "\u2022 History of deep venous thrombosis (DVT) in upper lymphedemic extremities", "Previous low-level laser treatment (regardless of indication)", "A known medicine(s) to affect body fluid balance", "Body Mass Index (BMI) > 40 (mortbid obesity)"], "Results": ["Performance measures:", "Volume of arms", "[Unspecified]", "Time limit: 13 months", "Results 1:", "Title of the arm/group: Placebo", "Description of the arm/group: CDT + LLL inactive", "Low-level laser therapy: Placebo LLL combined with CDT", "Total number of participants analysed: 10", "Average (standard deviation)", "Unit of measurement: cm^3 1.48 (1.01)", "Results 2:", "Title of the arm/group: LL Combined with CDT", "Description of the arm/group: CDT + active LLL", "Low-level Laser: Active LLL combined with CDT", "Total number of participants analysed: 11", "Average (standard deviation)", "Unit of measurement: cm^3 1.58 (1.0)"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/10 (0.00 per cent)", "Adverse Events 2:", "Total: 0/11 (0.00 per cent)"]}